Automated and Closed Cell Therapy Processing Systems

Global Automated and Closed Cell Therapy Processing Systems Market to Reach US$4.8 Billion by 2030

The global market for Automated and Closed Cell Therapy Processing Systems estimated at US$1.5 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 21.2% over the analysis period 2024-2030. Separation Workflow, one of the segments analyzed in the report, is expected to record a 24.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Expansion Workflow segment is estimated at 22.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$400.2 Million While China is Forecast to Grow at 19.9% CAGR

The Automated and Closed Cell Therapy Processing Systems market in the U.S. is estimated at US$400.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$732.4 Million by the year 2030 trailing a CAGR of 19.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.9% and 18.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Global Automated and Closed Cell Therapy Processing Systems Market - Key Trends & Drivers Summarized

Why Are Automated and Closed Systems Transforming Cell Therapy Processing?
Automated and closed cell therapy processing systems are revolutionizing cell therapy manufacturing by improving efficiency, reducing contamination risks, and ensuring consistent product quality. These systems integrate automated workflows for cell isolation, expansion, and preservation, streamlining the production of therapies such as CAR-T cells and stem cell-based treatments. By minimizing manual intervention, they enhance scalability and regulatory compliance, addressing critical challenges in cell therapy production. As the demand for cell-based therapies grows, automated systems are becoming indispensable for meeting industry needs.

What Trends Are Driving Innovation in Cell Therapy Processing?
Several trends are shaping the market for automated and closed cell therapy processing systems. The rise of personalized medicine has fueled demand for systems capable of producing patient-specific therapies. Technological advancements in automation and robotics are enabling precise and reproducible workflows. The integration of data analytics and IoT features is enhancing process monitoring and quality control. Additionally, the increasing focus on decentralizing manufacturing through point-of-care production is driving the adoption of compact and portable systems.

How Are These Systems Enhancing the Cell Therapy Ecosystem?
Automated and closed systems are enhancing the cell therapy ecosystem by addressing bottlenecks in manufacturing and ensuring product safety and efficacy. These systems enable rapid scale-up of production, facilitating the commercialization of therapies for larger patient populations. Real-time monitoring and traceability features improve compliance with stringent regulatory standards. Moreover, the ability to standardize processes across facilities ensures consistent quality, reducing variability in therapy outcomes. These contributions are accelerating the adoption of cell-based treatments across diverse therapeutic areas.

What Drives the Growth in the Automated and Closed Cell Therapy Processing Systems Market?
The growth in the automated and closed cell therapy processing systems market is driven by increasing demand for cell-based therapies, advancements in automation technologies, and regulatory requirements for consistent manufacturing practices. The rising prevalence of cancer and genetic disorders has created a robust demand for scalable production solutions. Collaborations between biopharma companies and technology providers are accelerating innovation and expanding market access. Additionally, government funding and initiatives supporting cell therapy research are fostering the adoption of automated systems, ensuring sustained market growth.

SCOPE OF STUDY:

The report analyzes the Automated and Closed Cell Therapy Processing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Workflow (Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow, Other Workflows); Type (Non-Stem Cell Therapy, Stem Cell Therapy)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

• BioSpherix®, LLC
• Cellares Corporation
• Cytiva
• Danaher Corporation
• Fresenius Kabi AG
• Lonza, Inc.
• Miltenyi Biotec
• Sartorius AG
• Terumo Corporation
• Thermo Fisher Scientific, Inc.
• ThermoGenesis Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.